Philips launched IntelliSpace Portal 9.0, the latest version of its advanced visual analysis and quantification platform at the Radiological Society of North America annual meeting, which took place in Chicago last week. This platform includes a variety of multimodality functions and neurological tools.
With IntelliSpace Portal 9.0’s new machine-learning functionality, radiologists can detect, diagnose, and follow up on the treatment of diseases. This platform can thus help radiologists in search of tools to support patients with brain injuries and neurological disorders including amyotrophic lateral sclerosis, dementia, and multiple sclerosis.
Philips’ platform hosts 70 applications and enhancements—all of which help radiologists, neurologists, oncologists, and cardiologists. These clinicians have access to advanced 3D rendering and stereolithography export, which provides access to in-depth insight into patients’ anatomy.
“As the rates of dementia and neurodegeneration rise, neuroradiologists need advanced tools to help referring physicians treat these challenging cases,” says Leo Wolansky, MD, acting chief of neuroradiology at University Hospitals Cleveland Medical Center. “IntelliSpace Portal 9.0 offers a comprehensive set of robust tools so neuroradiologists can quantify disease expediently.”
According to Yair Briman, senior vice president and general manager of healthcare information technology for Philips: “Radiology has a unique ability to influence and improve outcomes, and intelligent tools enable us to empower radiologists with the right information.”
For more information about this platform, visit Philips.
